Global Hepatitis B Vaccines Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Hepatitis B Vaccines Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Hepatitis B Vaccines Market Size Growth Rate by Type
  • 1.4.2 Yeast Derived
  • 1.4.3 CHO Derived
• 1.3 Market by Application
  • 1.3.1 Global Hepatitis B Vaccines Market Size Growth Rate by Application
  • 1.3.2 Children
  • 1.3.3 Adult
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Hepatitis B Vaccines Sales Estimates and Forecasts 2016-2027
• 2.2 Global Hepatitis B Vaccines Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Hepatitis B Vaccines Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Hepatitis B Vaccines Regions by Sales
  • 2.4.1 Global Top Hepatitis B Vaccines Regions by Sales (2016-2021)
  • 2.4.2 Global Top Hepatitis B Vaccines Regions by Sales (2022-2027)
• 2.5 Global Top Hepatitis B Vaccines Regions by Revenue
  • 2.5.1 Global Top Hepatitis B Vaccines Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Hepatitis B Vaccines Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Hepatitis B Vaccines Sales by Manufacturers
  • 3.1.1 Global Top Hepatitis B Vaccines Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Hepatitis B Vaccines Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccines Sales in 2020
• 3.2 Global Hepatitis B Vaccines Revenue by Manufacturers
  • 3.2.1 Global Top Hepatitis B Vaccines Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Hepatitis B Vaccines Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccines Revenue in 2020
• 3.3 Global Hepatitis B Vaccines Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Hepatitis B Vaccines Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Hepatitis B Vaccines Sales by Type
  • 4.1.1 Global Hepatitis B Vaccines Historical Sales by Type (2016-2021)
  • 4.1.2 Global Hepatitis B Vaccines Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Hepatitis B Vaccines Sales Market Share by Type (2016-2027)
• 4.2 Global Hepatitis B Vaccines Revenue by Type
  • 4.2.1 Global Hepatitis B Vaccines Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Hepatitis B Vaccines Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2016-2027)
• 4.3 Global Hepatitis B Vaccines Price by Type
  • 4.3.1 Global Hepatitis B Vaccines Price by Type (2016-2021)
  • 4.3.2 Global Hepatitis B Vaccines Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Hepatitis B Vaccines Sales by Application
  • 5.1.1 Global Hepatitis B Vaccines Historical Sales by Application (2016-2021)
  • 5.1.2 Global Hepatitis B Vaccines Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Hepatitis B Vaccines Sales Market Share by Application (2016-2027)
• 5.2 Global Hepatitis B Vaccines Revenue by Application
  • 5.2.1 Global Hepatitis B Vaccines Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Hepatitis B Vaccines Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2016-2027)
• 5.3 Global Hepatitis B Vaccines Price by Application
  • 5.3.1 Global Hepatitis B Vaccines Price by Application (2016-2021)
  • 5.3.2 Global Hepatitis B Vaccines Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Hepatitis B Vaccines Market Size by Type
  • 6.1.1 North America Hepatitis B Vaccines Sales by Type (2016-2027)
  • 6.1.2 North America Hepatitis B Vaccines Revenue by Type (2016-2027)
• 6.2 North America Hepatitis B Vaccines Market Size by Application
  • 6.2.1 North America Hepatitis B Vaccines Sales by Application (2016-2027)
  • 6.2.2 North America Hepatitis B Vaccines Revenue by Application (2016-2027)
• 6.3 North America Hepatitis B Vaccines Market Size by Country
  • 6.3.1 North America Hepatitis B Vaccines Sales by Country (2016-2027)
  • 6.3.2 North America Hepatitis B Vaccines Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Hepatitis B Vaccines Market Size by Type
  • 7.1.1 Europe Hepatitis B Vaccines Sales by Type (2017-2027)
  • 7.1.2 Europe Hepatitis B Vaccines Revenue by Type (2017-2027)
• 7.2 Europe Hepatitis B Vaccines Market Size by Application
  • 7.2.1 Europe Hepatitis B Vaccines Sales by Application (2017-2027)
  • 7.2.2 Europe Hepatitis B Vaccines Revenue by Application (2017-2027)
• 7.3 Europe Hepatitis B Vaccines Market Size by Country
  • 7.3.1 Europe Hepatitis B Vaccines Sales by Country (2017-2027)
  • 7.3.2 Europe Hepatitis B Vaccines Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Hepatitis B Vaccines Market Size by Type
  • 8.1.1 Asia Pacific Hepatitis B Vaccines Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Hepatitis B Vaccines Revenue by Type (2018-2027)
• 8.2 Asia Pacific Hepatitis B Vaccines Market Size by Application
  • 8.2.1 Asia Pacific Hepatitis B Vaccines Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Hepatitis B Vaccines Revenue by Application (2018-2027)
• 8.3 Asia Pacific Hepatitis B Vaccines Market Size by Region
  • 8.3.1 Asia Pacific Hepatitis B Vaccines Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Hepatitis B Vaccines Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Hepatitis B Vaccines Market Size by Type
  • 9.1.1 Latin America Hepatitis B Vaccines Sales by Type (2019-2027)
  • 9.1.2 Latin America Hepatitis B Vaccines Revenue by Type (2019-2027)
• 9.2 Latin America Hepatitis B Vaccines Market Size by Application
  • 9.2.1 Latin America Hepatitis B Vaccines Sales by Application (2019-2027)
  • 9.2.2 Latin America Hepatitis B Vaccines Revenue by Application (2019-2027)
• 9.3 Latin America Hepatitis B Vaccines Market Size by Country
  • 9.3.1 Latin America Hepatitis B Vaccines Sales by Country (2019-2027)
  • 9.3.2 Latin America Hepatitis B Vaccines Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Hepatitis B Vaccines Market Size by Type
  • 6.1.1 Middle East and Africa Hepatitis B Vaccines Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Hepatitis B Vaccines Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Hepatitis B Vaccines Market Size by Application
  • 6.2.1 Middle East and Africa Hepatitis B Vaccines Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Hepatitis B Vaccines Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Hepatitis B Vaccines Market Size by Country
  • 6.3.1 Middle East and Africa Hepatitis B Vaccines Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Hepatitis B Vaccines Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 UAE

11 Company Profiles

• 11.1 GSK
  • 11.1.1 GSK Corporation Information
  • 11.1.2 GSK Overview
  • 11.1.3 GSK Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 GSK Hepatitis B Vaccines Product Description
  • 11.1.5 GSK Related Developments
• 11.2 NCPC
  • 11.2.1 NCPC Corporation Information
  • 11.2.2 NCPC Overview
  • 11.2.3 NCPC Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 NCPC Hepatitis B Vaccines Product Description
  • 11.2.5 NCPC Related Developments
• 11.3 Merck
  • 11.3.1 Merck Corporation Information
  • 11.3.2 Merck Overview
  • 11.3.3 Merck Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Merck Hepatitis B Vaccines Product Description
  • 11.3.5 Merck Related Developments
• 11.4 Bio Kangtai
  • 11.4.1 Bio Kangtai Corporation Information
  • 11.4.2 Bio Kangtai Overview
  • 11.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Bio Kangtai Hepatitis B Vaccines Product Description
  • 11.4.5 Bio Kangtai Related Developments
• 11.5 Dynavax
  • 11.5.1 Dynavax Corporation Information
  • 11.5.2 Dynavax Overview
  • 11.5.3 Dynavax Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Dynavax Hepatitis B Vaccines Product Description
  • 11.5.5 Dynavax Related Developments
• 11.6 Hissen
  • 11.6.1 Hissen Corporation Information
  • 11.6.2 Hissen Overview
  • 11.6.3 Hissen Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Hissen Hepatitis B Vaccines Product Description
  • 11.6.5 Hissen Related Developments
• 11.7 KM Biologics
  • 11.7.1 KM Biologics Corporation Information
  • 11.7.2 KM Biologics Overview
  • 11.7.3 KM Biologics Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 KM Biologics Hepatitis B Vaccines Product Description
  • 11.7.5 KM Biologics Related Developments
• 11.8 LG Life Sciences
  • 11.8.1 LG Life Sciences Corporation Information
  • 11.8.2 LG Life Sciences Overview
  • 11.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 LG Life Sciences Hepatitis B Vaccines Product Description
  • 11.8.5 LG Life Sciences Related Developments
• 11.9 Serum Institute
  • 11.9.1 Serum Institute Corporation Information
  • 11.9.2 Serum Institute Overview
  • 11.9.3 Serum Institute Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Serum Institute Hepatitis B Vaccines Product Description
  • 11.9.5 Serum Institute Related Developments
• 11.1 GSK
  • 11.1.1 GSK Corporation Information
  • 11.1.2 GSK Overview
  • 11.1.3 GSK Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 GSK Hepatitis B Vaccines Product Description
  • 11.1.5 GSK Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Hepatitis B Vaccines Value Chain Analysis
• 12.2 Hepatitis B Vaccines Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Hepatitis B Vaccines Production Mode & Process
• 12.4 Hepatitis B Vaccines Sales and Marketing
  • 12.4.1 Hepatitis B Vaccines Sales Channels
  • 12.4.2 Hepatitis B Vaccines Distributors
• 12.5 Hepatitis B Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Hepatitis B Vaccines Industry Trends
• 13.2 Hepatitis B Vaccines Market Drivers
• 13.3 Hepatitis B Vaccines Market Challenges
• 13.4 Hepatitis B Vaccines Market Restraints

14 Key Findings in The Global Hepatitis B Vaccines Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details